BioSkryb: BioSkryb Genomics to Present Novel Research on Tumor Heterogeneity at American Association for Cancer Research (AACR) Annual Meeting 2024
DURHAM, N.C.--(BUSINESS WIRE)--BioSkryb will highlight its new automation-ready ResolveDNA® and ResolveOME single-cell core kits and share new breast cancer research at AACR 2024
Read full article »
BioSkryb is a North Carolina-based company that provides services such as single-cell molecular discovery and analysis for the biotech industry.
Read more